cyclosporine has been researched along with Hepatitis C in 207 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 60 (28.99) | 18.2507 |
| 2000's | 78 (37.68) | 29.6817 |
| 2010's | 65 (31.40) | 24.3611 |
| 2020's | 4 (1.93) | 2.80 |
| Authors | Studies |
|---|---|
| Coelmont, L; Dumont, JM; Kaptein, S; Neyts, J; Paeshuyse, J; Vliegen, I; Vuagniaux, G | 1 |
| Erdmann, F; Fischer, G; Harris, R; Hopkins, S; Huang, Z; Murray, MG; Ribeill, Y; Scorneaux, B; Smitley, C; Wring, S | 1 |
| Fu, J; Sweeney, ZK; Wiedmann, B | 1 |
| Ahn, HJ; Akter, S; Cho, WJ; Choi, TG; Ha, J; Jang, M; Jin, Y; K R, J; Kang, I; Khadka, DB; Kim, HY; Kim, JH; Kim, M; Kim, SS; Lim, S; Oh, BC; Windisch, MP; Yang, S; Zhao, C | 1 |
| Chang, YL; Chou, YC; Hsu, CC; Huang, YH; Huang, YY; Loong, CC; Wu, TH | 1 |
| Huber, AD; Ji, J; Liu, D; Michailidis, E; Ndongwe, TP; Ralston, R; Rice, CM; Sarafianos, SG; Tedbury, PR | 1 |
| Buchanan, FJT; Chen, S; Harris, M; Herod, MR | 1 |
| Akarca, US; Danış, N; Ersöz, G; Günşar, F; Karasu, Z; Özkahya, M; Toz, H; Turan, İ; Ünal, N; Yılmaz, M | 1 |
| Barrett, D; Ishida, J; Makino, T; Ohki, H; Sawada, M; Uchida, M; Yamanaka, T | 1 |
| Frey, A; Gerken, G; Herzer, K; Piras-Straub, K; Timm, J; Walker, A | 1 |
| Huang, F; Rowland, L; Sabo, JP; Schultz, A; Trampisch, M; Voelk, C | 1 |
| Ahmed-Belkacem, A; Ahnou, N; Baudesson, C; Brillet, R; Bruscella, P; Chazal, M; Donati, F; Fourati, S; Gelin, M; Guichou, JF; Jouvenet, N; Nevers, Q; Pawlotsky, JM; Ruiz, I; Softic, L | 1 |
| Bigi, L; Conti, A; Lasagni, C; Pellacani, G | 1 |
| Barrail-Tran, A; Botta-Fridlund, D; Cagnot, C; Canva, V; Coilly, A; Conti, F; D'Alteroche, L; Danjou, H; De Ledinghen, V; Duclos-Vallée, JC; Durand, F; Duvoux, C; Fougerou-Leurent, C; Gelé, T; Goldwirt, L; Houssel-Debry, P; Kamar, N; Laforest, C; Lavenu, A; Leroy, V; Moreno, C; Pageaux, GP; Radenne, S; Samuel, D; Taburet, AM | 1 |
| Duvoux, C; Firpi, R; Grazi, GL; Levy, G; Renner, E; Villamil, F | 1 |
| Gallay, PA; Lin, K | 1 |
| Fathy, A; Khashab, S; Shaheen, N; Soliman, A; Soliman, M | 1 |
| Chiba, T; Fujimoto, Y; Hashi, S; Hashimoto, E; Ito, T; Kaido, T; Kawai, T; Kikuchi, M; Masuda, S; Matsubara, K; Nishioka, Y; Okuda, Y; Omura, T; Shinke, H; Takahashi, T; Ueda, Y; Uemoto, S; Uesugi, M; Yonezawa, A | 1 |
| Guedj, J; Kern, S; Levi, M; Li, B; Naoumov, NV; Perelson, AS; Yu, J | 1 |
| Clavien, PA; Jones, R; Klintmalm, G; Levy, G; Metselaar, HJ; Migliaccio, M; Nevens, F; Orsenigo, R; Prestele, H; Villamil, FG | 1 |
| Ampuero, J; Reddy, KR; Romero-Gómez, M | 1 |
| Baugh, J; Brass, CA; Chatterji, U; Gallay, PA; Garcia-Rivera, JA; Gawlik, K; Naoumov, NV; Wong, KA; Zhong, W | 1 |
| Balsarotti, J; Briley, A; Dufner-Beattie, J; Noueiry, A; O'Guin, A; O'Guin, S; Olivo, PD; Rice, CM; Roth, R; Slomczynska, U; Starkey, G; Wang, B | 1 |
| Czock, D; Eisenbach, C; Giese, T; Gotthardt, D; Roos, K; Schnitzler, P; Stremmel, W | 1 |
| Guedj, J; Levi, M; Mentré, F; Nguyen, TH; Yu, J | 1 |
| Chen, Y; Liu, Z; Meng, J; Tao, R; Xv, J; Yong, X | 1 |
| Chen, HX; Chen, P; Lan, X; Liu, HM; Liu, MG; Wei, D; Zeng, W | 1 |
| Becker, C; Bednarczyk, D; Capparelli, M; Elling, R; Fu, J; Fujimoto, R; Furegati, M; Hanna, I; Karur, S; Kasprzyk, T; Knapp, M; Leung, K; Li, X; Lu, P; Mergo, W; Miault, C; Ng, S; Parker, D; Peng, Y; Rivkin, A; Roggo, S; Simmons, RL; Sweeney, ZK; Tjandra, M; Wang, M; Weiss, AH; Wiedmann, B; Xiao, L; Xie, L; Xu, W; Yang, S; Yifru, A; Zhou, B | 1 |
| Akter, S; Baik, HH; Beloor, J; Choi, TG; Ha, J; Jo, A; Jyothi, KR; Kang, I; Kim, JH; Kim, SS; Lee, SK; Maeng, CH; Nguyen, MN | 1 |
| Awni, W; Badri, P; Bernstein, B; Coakley, E; Cohen, D; Ding, B; Dutta, S; Menon, R; Podsadecki, T | 1 |
| Aikata, H; Chayama, K; Fujino, H; Fukuhara, T; Hayes, CN; Hiramatsu, A; Honda, Y; Imamura, M; Ishiyama, K; Kan, H; Kawakami, Y; Kawaoka, T; Kobayashi, T; Naeshiro, N; Ochi, H; Ohdan, H; Tashiro, H; Tsuge, M | 1 |
| Beumont, M; Monshouwer, M; Ouwerkerk-Mahadevan, S; Snoeys, J | 1 |
| Handisurya, A; Herkner, H; Kautzky-Willer, A; Kerscher, C; Mandorfer, M; Pacini, G; Payer, BA; Reiberger, T; Säemann, M; Schmidt, A; Tura, A; Werzowa, J; Winnicki, W | 1 |
| Awni, WM; Badri, PS; Coakley, EP; Ding, B; Dutta, S; Menon, RM; Parikh, A | 1 |
| Bobardt, M; Chatterji, U; Gallay, PA; Schaffer, L; Wood, M | 1 |
| Hwang, S; Joh, JW; Jung, BH; Kim, JM; Kwon, CD; Lee, HW; Lee, KW; Lee, SG; Lee, SK; Song, GW; Suh, KS; Yi, NJ | 1 |
| D'Angelo, S; Olivieri, I; Palazzi, C | 1 |
| Balan, V; Demetris, AJ; Detre, KM; Duquesnoy, RJ; Everhart, JE; Ledneva, T; Rakela, J; Roberts, JP; Ruppert, K; Schafer, DF; Wei, YL; Wiesner, RH | 1 |
| Agnelli, F; Arosio, E; Colombo, M; Donato, MF; Rigamonti, C | 1 |
| Fuchinoue, S; Imaizumi, R; Nakajima, I; Nanmoku, K; Sakamoto, N; Teraoka, S; Tojimbara, T; Watanabe, M | 1 |
| Akamatsu, Y; Fujimori, K; Kawagishi, N; Miyagi, S; Sato, A; Satomi, S; Sekiguchi, S | 1 |
| Cassano, N; Vena, GA | 1 |
| Bilodeau, M; Ethier, C; Houle, R; Jouan, L; Lamarre, D; Maniere, T; Raymond, VA; Selliah, S; Willems, B | 1 |
| Cerquaglia, C; Curigliano, V; De Socio, G; Fonnesu, C; Gasbarrini, G; Giovinale, M; Granata, M; Manna, R; Massafra, U; Migliore, A; Soriano, A; Verrecchia, E | 1 |
| Cescon, M; Cucchetti, A; Ercolani, G; Grazi, GL; Morelli, MC; Pinna, AD; Piscaglia, F; Ravaioli, M; Tamè, M; Vetrone, G | 1 |
| Lee, PH; Tsai, MK; Wu, MS; Yang, CY | 1 |
| Gallay, PA | 1 |
| Abradelo, M; Colina, F; Fernández, I; Gimeno, A; Jiménez, C; Lumbreras, C; Meneu, JC; Moreno, E; Solís-Herruzo, JA; Ulloa, E | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, V; Dammann, M; Gensicke, J; Kaiser, GM; Koeppen, S; Malagó, M; Nadalin, S; Olde Damink, SW; Paul, A; Pavlaković, G; Radtke, A; Saner, FH; Sotiropoulos, GC; Treckmann, J | 1 |
| Cabrera, R; Chen, C; Clark, VC; Firpi, RJ; Levy, C; Michaels, A; Morelli, GG; Nelson, DR; Soldevila-Pico, C; Suman, A | 1 |
| Auriault, C; Boleslowski, E; Carpentier, A; Conti, F; Delhem, N; Dharancy, S; Miroux, C; Moralès, O; Pancré, V; Podevin, P | 1 |
| Watashi, K | 1 |
| Choi, GS; Joh, JW; Jung, GO; Kim, EY; Kim, JM; Kim, SJ; Kwon, CH; Lee, SK; Moon, JI; Shin, M | 1 |
| Angelico, M; Angelico, R; Brega, A; Di Paolo, D; Manzia, TM; Sforza, D; Tisone, G; Toti, L | 1 |
| Campanella, L; Cuomo, O; Esposito, C; Ioia, G; Perrella, A; Taglialatela, D | 1 |
| Fischer, G; Gallay, P; Hopkins, S | 1 |
| Bartenschlager, R; Bienkiewicz, E; Frausto, S; Greenstein, AE; Grise, H; Logan, TM; Madan, V; Nag, A; Robinson, M; Robotham, JM; Tang, H; Yang, F; Zayas, M | 1 |
| Heathcote, EJ; Patel, H | 1 |
| Ho, WZ; Li, JL; Liu, JP; Wang, X; Ye, L | 1 |
| Aguilera, V; Benlloch, S; Berenguer, M; de Juan, M; López-Andujar, R; Mir, J; Montalva, E; Moya, A; Pareja, E; Prieto, M; Rubin, A; San Juan, F; Yago, M | 1 |
| Bassendine, MF; Burt, AD; Hudson, M; Kazemier, G; Kwekkeboom, J; Lindsay, AS; McPherson, S; Metselaar, HJ; Thomas, RC; Tilanus, HW; van der Laan, LJ; Zondervan, PE | 1 |
| Evans, TG; Godofsky, E; Huang, M; Ke, J; Lawitz, E; Marbury, T; Nguyen, T; Praestgaard, J; Rouzier, R; Serra, D | 1 |
| Arvelakis, A; Assis, D; Caldwell, C; Cimsit, B; Emre, S; Kulkarni, S; Schilsky, M; Taddei, T | 1 |
| Fujikawa, T; Fujita, S; Hemming, AW; Kim, RD; Mizuno, S; Schwartz, JJ; Sorensen, JB | 1 |
| Alves, K; Garg, V; Lee, JE; Luo, X; Nadkarni, P; van Heeswijk, R | 1 |
| Charlton, M | 1 |
| Berenguer, M | 1 |
| Asthana, S; Dibben, C; Douglas, D; Kneteman, NM; Lewis, J; Lund, G; Nourbakhsh, M; Tyrrell, LJ | 1 |
| Fujita, S; Kim, RD; Mizuno, S; Schwartz, JJ; Sorensen, JB | 1 |
| Burroughs, AK; Germani, G; Samonakis, DN | 1 |
| Rosen, HR; Rutebemberwa, A | 1 |
| Flisiak, I; Flisiak, R; Jaroszewicz, J; Łapiński, T | 1 |
| de Mare-Bredemeijer, EL; Metselaar, HJ | 1 |
| Butterton, J; Feng, HP; Gupta, S; Hulskotte, E; O'Mara, E; van Zutven, M; Wagner, J; Xuan, F | 1 |
| Boillot, O; Botta-Fridlund, D; Boudjema, K; Calmus, Y; Chazouillères, O; Dharancy, S; Durand, F; Duvoux, C; Gugenheim, J; Néau-Cransac, M; Pageaux, G; Rostaing, L; Samelson, L; Samuel, D; Vanlemmens, C; Wolf, P | 1 |
| Mumtaz, K; Rabie, R; Renner, EL | 1 |
| Fukazawa, H; Murakami, Y; Suzuki, T; Wakita, T | 1 |
| Gao, Y; Kohara, M; Shimotohno, K; Tian, X; Toyoda, T; Wakita, T; Watashi, K; Weng, L | 1 |
| Bahra, M; Boas-Knoop, S; Eurich, D; Kiessling, A; Neuhaus, P; Neuhaus, R; Neumann, UP; Puhl, G; Trautwein, C; Wasmuth, H; Yahyazadeh, A | 1 |
| Garcia-Saenz-de-Sicilia, M; Mukherjee, S | 1 |
| Chan, AJ; Lake, JR | 1 |
| Espinales, JC; Lawitz, EJ; Membreno, FE | 1 |
| Allen, T; Ansari, IU; Barin, B; Berical, A; Stock, PG; Striker, R | 1 |
| Garton, T | 1 |
| Bahra, M; Berg, T; Harren, M; Jacob, D; Langrehr, JM; Neuhaus, P; Neuhaus, R; Neumann, UP | 1 |
| Benet, LZ; Hebert, MF; Roberts, JP; Wacher, VJ | 1 |
| Cotler, SJ; Jensen, DM; Layden, TJ; Morrissey, MJ; Wiley, TE | 1 |
| Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Tur-Kaspa, R | 1 |
| Femiano, F; Gombos, F; Scully, C | 1 |
| Buchler, M; Durand, D; Izopet, J; Kamar, N; Rostaing, L; Sandres-Saune, K; Toupance, O | 1 |
| Berg, U; Englund, M; Tydén, G | 1 |
| Bak, T; Everson, GT; Forman, L; Kam, I; Kugelmas, M; Osgood, MJ; Trotter, JF; Wachs, M | 1 |
| Gleeson, M; Guney, S; McCaughan, GW; Zekry, A | 1 |
| Kawauchi, K; Ogasawara, T; Ohkawa, S; Takei, K; Yasuyama, M | 1 |
| Jabur, P; Malafronte, P; Miorin, LA; Sens, YA; Silva, VD; Souza, JF | 1 |
| Akalin, E; Ames, S; Bromberg, JS; Daly, L; Murphy, B; Sehgal, V | 1 |
| Inoue, K; Yoshiba, M | 2 |
| Busuttil, RW; Crippin, JS; Fitzsimmons, WE; Goldstein, RM; Klintmalm, GB; Martin, P; Uleman, C | 1 |
| Hommann, M; Kornberg, A; Küpper, B; Scheele, J; Tannapfel, A | 1 |
| Agnes, S; Burra, P; Callea, F; De Carlis, L; Fassati, LR; Ferrara, R; Filipponi, F; Grazi, GL; Pisati, R; Risaliti, A; Rossi, M; Salizzoni, M; Valente, U | 1 |
| Acosta, D; Astorga, R; Escobar, MJ; Gentil, MA; López Hidalgo, R; Sánchez Ibáñez, R | 1 |
| Burroughs, AK; Davidson, BR; Davies, S; Dhillon, AP; Emery, V; Griffiths, P; Leandro, G; Papatheodoridis, GV; Patch, DW; Quaglia, A; Rolando, N; Rolles, K; Sabin, CA; Samonakis, DN; Teixeira, R; Thalheimer, U; Triantos, CK | 1 |
| Bahra, M; Jacob, D; Langrehr, JM; Neuhaus, P; Neumann, UP | 1 |
| Angelico, M; Anselmo, A; D'Andria, D; de Liguori Carino, N; de'Liguori Carino, N; Ielpo, B; Manzia, T; Muzi, F; Orlando, G; Sabato Ceraldi, S; Tariciotti, L; Tisone, G | 1 |
| Bromberg, J; Dixit, V; Elli, A; Fabrizi, F; Martin, P | 1 |
| Brunati, A; Cerutti, E; David, E; Franchello, A; Gennari, F; Lavezzo, B; Lupo, F; Marzano, A; Ottobrelli, A; Ricchiuti, A; Rizzetto, M; Romagnoli, R; Salizzoni, M; Schellino, MM; Strignano, P; Zamboni, F | 1 |
| Shimotohno, K; Watashi, K | 1 |
| Rice, CM; You, S | 1 |
| Angelico, M; Anselmo, A; Baiocchi, L; Cardillo, A; Lionetti, R; Manzia, TM; Orlando, G; Palmieri, G; Tisone, G; Toti, L | 1 |
| Aguilera, V; Benlloch, S; Berenguer, J; Berenguer, M; Prieto, M; Rayón, JM; San Juan, F | 2 |
| Baliellas, C; Castellote, J; Fabregat, J; Figueras, J; Garcia-Gil, A; Gonzalez-Pinto, I; Lladó, L; Memba, R; Rafecas, A; Ramos, E; Serrano, T; Torras, J; Xiol, X | 1 |
| Lake, JR | 1 |
| Bartenschlager, R; De Clercq, E; Dumont, JM; Kaul, A; Neyts, J; Paeshuyse, J; Rosenwirth, B; Scalfaro, P | 1 |
| Bellisai, F; Galeazzi, M; Manganelli, S; Morozzi, G; Sebastiani, GD | 1 |
| Kaneko, J; Makuuchi, M; Sugawara, Y | 1 |
| Cillo, U; Grazi, GL; Lake, J; Leonardi, L; Levy, G; Mies, S; Mühlbacher, F; Munn, S; Rossi, M; Samuel, D; Sanjuan, F; Villamil, F | 1 |
| Arichi, N; Fujii, N; Ichikawa, Y; Kishikawa, H; Kyo, M; Nishikawa, M; Nishimura, K; Tokugawa, S; Yoshioka, I | 1 |
| Barbeito, R; Katz, D; Kirby, P; Labrecque, D; Miller, R; Rayhill, SC; Schmidt, W; Stolpen, A; Voigt, M; Wu, Y | 1 |
| Berenguer, M; Royuela, A; Zamora, J | 1 |
| Dumont, JM; Inoue, K; Kohara, M; Ruegg, UT; Scalfaro, P; Umehara, T; Watanabe, T; Yasuda, H; Yasui, F; Yoshiba, M | 1 |
| Al Najjar, A; Benhamou, PY; Cassuto, E; Cointault, O; Dantal, J; Delahousse, M; Di Giambattista, F; Kamar, N; Lefrançois, N; Mariat, C; Touchard, G; Villemain, F | 1 |
| Bärthel, E; Hommann, M; Kornberg, A; Küpper, B; Settmacher, U; Tannapfel, A; Thrum, K; Wilberg, J | 1 |
| Boki, K; Ioannidou, P; Karafoulidou, A; Katsarou, O; Linardaki, G | 1 |
| Boroń-Kaczmarska, A; Herman, E; Jurczyk, K; Karpińska, E; Laurans, Ł; Lubikowski, J; Wawrzynowicz-Syczewska, M | 1 |
| Andrei, AC; Fernandes, F; Gerstner, J; Hoover, S; Middleton, R; Poole, DS; Striker, R | 1 |
| Gallegos-Orozco, JF; Olivera-Martínez, MA | 1 |
| Bellisai, F; Galeazzi, M; Giannitti, C; Manganelli, S; Morozzi, G; Sebastiani, GD | 1 |
| Dahari, H; Perelson, AS | 1 |
| Durand, D; Esposito, L; Faguer, S; Guitard, J; Kamar, N; Lavayssière, L; Lavit, M; Muscari, F; Péron, JM; Ribes, D; Rostaing, L; Sandres-Sauné, K | 1 |
| Aeschlimann, C; Bobardt, M; Cielniak, I; Crabbé, R; Dumont, JM; Flisiak, R; Gallay, P; Grosgurin, P; Higersberger, J; Horban, A; Kierkus, J; Nicolas-Métral, V; Porchet, H; Scalfaro, P; Selvarajah, S; Siwak, E; Wiercinska-Drapalo, A | 1 |
| Metselaar, HJ; van der Laan, LJ; Watashi, K | 1 |
| Eguchi, S; Hamasaki, K; Hidaka, M; Ichikawa, T; Kanematsu, T; Miyazaki, K; Soyama, A; Tajima, Y; Takatsuki, M; Tokai, H | 1 |
| Cheng, JC; Lai, HY; Yeh, CT; Yeh, YJ | 1 |
| Bang, BK; Chang, YS; Kim, YS; Koh, YB; Yang, CW; Yoon, SA; Yoon, YS | 1 |
| Jindal, RM; Popescu, I | 1 |
| Demetris, AJ; Manez, R; Starzl, TE | 1 |
| Inoue, K; Sekiyama, K; Yoshiba, M | 1 |
| Bechstein, WO; Blumhardt, G; Christe, W; Mueller, AR; Neuhaus, P; Platz, KP | 1 |
| Albani, AP; Doglia, M; Fassati, LR; Ferla, G; Galmarini, D; Gatti, S; Orsenigo, R; Reggiani, P | 1 |
| Bechstein, WO; Blumhardt, G; Hop, U; Lobeck, H; Mueller, AR; Neuhaus, P; Platz, KP | 1 |
| Castells, L; Charco, R; Esteban, R; Margarit, C; Vargas, V | 1 |
| Fujimoto, N; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Ihara, H; Kyo, M; Nagano, S; Nakayama, K; Nishiuchi, M; Shinji, Y | 1 |
| Yoshiba, M | 1 |
| Górriz, JL; Pallardó, LM; Rochera, A; Sánchez, J; Sarrión, A | 1 |
| Bismuth, H; Cabiac, MD; Farges, O; Girault, D; Haddad, N; Samuel, D | 1 |
| Ascher, NL; Ferrell, LD; Hebert, M; Lake, JR; Nikolai, B; Roberts, JP | 1 |
| Fujita, R; Inoue, K; Sekiyama, K; Yoshiba, M | 1 |
| Chevallier, P; Chossegros, P; Daoud, S; Dubernard, JM; Garnier, JL; Touraine, JL | 1 |
| Baron, E; Duffaut, M; Durand, D; Izopet, J; Puel, J; Rostaing, L | 1 |
| Belghiti, J; Benhamou, JP; Bernuau, JR; Degott, C; Durand, F; Erlinger, S; Gadano, AC; Marcellin, P; Martinot-Peignoux, M; Mosnier, JF | 1 |
| Airoldi, A; Alberti, A; Bellati, G; Belli, LS; De Carlis, L; Fesce, E; Rondinara, GF; Rossetti, O; Zoppi, F; Zurleni, F | 1 |
| Kushibiki, Y; Omata, F; Takahashi, H; Ueno, F | 1 |
| Holzer, H; Horina, JH; Kenner, L; Krejs, GJ; Wirnsberger, GH | 1 |
| Alberti, A; Belli, LS; Bettale, G; De Carlis, L; Dughetti, L; Ideo, G; Rimoldi, P; Romani, F; Rondinara, GF; Sberna, M | 1 |
| Baron, E; Chabannier, MH; Cisterne, JM; Durand, D; Modesto, A; Rostaing, L; Suc, JM; Tkaczuk, J | 1 |
| Funaoka, M; Hoshino, T; Ishii, T; Kato, J; Kato, K; Komatsu, M; Kuramitsu, T; Masamune, O; Ono, T; Toyoshima, I | 1 |
| Brunkhorst, R; Flik, J; Frei, U; Kliem, V; Koch, KM; Manns, MP; Pichlmayr, R; Tillmann, HL; van den Hoff, U | 1 |
| Bechstein, WO; Berg, T; Fukomoto, T; Guckelberger, O; Hopf, U; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP | 1 |
| Bechstein, WO; Guckelberger, O; Jonas, S; Lobeck, H; Neuhaus, P; Neuhaus, R; Rayes, N; Riess, H; Schmidt, G; Tullius, SG; Vogl, T | 1 |
| Kierkuś, J; Ksiazyk, J; Lyszkowska, M; Popińska, K; Socha, J | 1 |
| Lengyel, G | 1 |
| Aiyama, T; Ishikawa, T; Iwata, K; Kakumu, S; Nadai, M; Okumura, A; Takayanagi, M; Yoshioka, K | 1 |
| Fujikawa, H; Kako, M; Miyakawa, H; Nagai, K | 1 |
| Berg, T; Guckelberger, O; Hopf, U; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP | 1 |
| Berenguer, J; Casanova, B; Deya, E; Gisbert, C; Mir, J; Prieto, M; Vilchez, JJ | 1 |
| Fragulidis, GP; Kato, T; Khan, MF; Miller, J; Nery, JR; Pinna, AD; Reddy, KR; Torres, MB; Tzakis, AG; Weppler, D; Zervos, XA | 2 |
| Berenguer, J; Berenguer, M; Carrasco, D; Córdoba, J; Gobernado, M; Mir, J; Olaso, V; Prieto, M; Rayón, JM; San-Juan, F | 1 |
| Andres, A; Castellanos, F; Cubas, A; Herrero, JC; Manzanares, C; Morales, JM; Morales-Ruiz, E; Moreno, M; Segura, J | 1 |
| Arnaud, C; Cisterne, JM; Duffaut, M; Durand, D; Izopet, J; Puel, J; Rostaing, L; Rumeau, JL | 1 |
| Burgos, FJ; Crespo, M; Liaño, F; Marcén, R; Mateos, ML; Orofino, L; Ortuño, J; Pascual, J | 1 |
| Born, G; Froschauer, R; Gralka, S; Hohenberger, W; Köckerling, F; Müller, V; Ott, R; Reck, T | 1 |
| Berg, T; Hopf, U; Lobeck, H; Mansoorian, B; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP; Willimski, C | 1 |
| Arnout, W; Busuttil, RW; Colquhoun, S; Drazan, K; Farmer, DG; Ghobrial, RM; Goldstein, LI; Goss, J; Hollis, P; Holt, CD; Imagawa, D; Markman, JF; Markowitz, J; Martin, P; Pakrasi, A; Ponthieux, S; Rosen, H; Seu, P; Shackleton, CR; Singer, J; Stribling, R; Yersiz, H | 1 |
| Cienfuegos, JA; Civeira, MP; de la Peña, A; García, N; Herrero, JI; Prieto, J; Quiroga, J; Sangro, B; Sola, I | 1 |
| Camarena, C; Castellano, F; Jara, P; Manzanares, C; Manzanares, J; Medina, E; Moreno, M; Urruzuno, P | 1 |
| Afonso, R; Bastos, J; Gunson, B; McMaster, P; Min, X | 1 |
| Caccamo, L; Colledan, M; Fassati, LR; Gridelli, B; Maggi, U; Reggiani, P; Rossi, G | 1 |
| Aroldi, A; Colombo, M; Elli, A; Lampertico, P; Lunghi, G; Montagnino, G; Ponticelli, C; Tarantino, A | 1 |
| Callea, F; Carli, O; Chiappini, R; Favret, M; Maiorca, R; Matricardi, L; Puoti, M; Sandrini, S; Setti, G | 1 |
| Berg, T; Hopf, U; Mansoorian, B; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP; Radke, C; Willimski, C | 1 |
| Andreani, P; Caccamo, L; Fassati, LR; Gatti, S; Latham, L; Maggi, U; Melada, E; Paone, G; Reggiani, P; Rossi, G; Vannelli, A | 1 |
| Isonokami, M; Itoh, Y; Kozuka, T; Kurachi, K; Matsumoto, Y; Miura, H; Tanabe, N; Tani, M | 1 |
| Angelico, M; Anselmo, A; Baiocchi, L; Casciani, CU; Negrini, S; Orlando, G; Palmieri, G; Pisani, F; Tisone, G; Vennarecci, G | 1 |
| Baquerizo, A; Busuttil, RW; Colquhoun, S; Drazan, KE; Farmer, DG; Ghobrial, RM; Goldstein, LI; Holt, C; Imagawa, D; Markmann, JF; Martin, P; Rosen, HR; Yersiz, H | 1 |
| Boletis, JN; Delladetsima, JK; Hatzakis, A; Kostakis, A; Makris, F; Psichogiou, M | 1 |
| Iadrikhinskaia, VN; Mikhaĭlova, EA; Savchenko, VG | 1 |
| Brandão, AB; Cantisani, GP; Cassal, AP; Diehl, JL; Hoppe, L; Leipnitz, I; Marroni, CA; Schlindwein, E; Zanotelli, ML | 1 |
| Angelico, M; Bellanova, G; Buonomo, O; Casciani, CU; Laria, G; Orlando, G; Palmieri, GP; Pisani, F; Tisone, G; Torri, E | 1 |
| Chejfec, G; Gaweco, AS; Hamdani, R; Harig, J; McClatchey, KD; Porayko, M; Rustgi, VK; Van Thiel, DH; Wiesner, RH; Yong, S | 1 |
| Ersoy, FF; Süleymanlar, G; Tuncer, M; Yakupoğlu, G | 1 |
| Colonna, J; Heyman, M; Howell, C; Kennedy, AS; Koffman, BH | 1 |
| Sheiner, PA | 1 |
| Berr, F; Hartwig, T; Hauss, J; Kohlhaw, K; Lübke, P; Schwarz, R | 1 |
| Broelsch, CE; Fischer, L; Gahlemann, CG; Malago, M; Rogiers, X; Sterneck, M | 1 |
| Allende, E; Bilbao, I; Charco, R; Hidalgo, E; Lázaro, JL; Margarit, C; Pou, L | 1 |
| Burroughs, AK; Papatheodoridis, GV; Teixeira, R | 1 |
| Antinori, A; Chiusolo, P; Cingolani, A; De Luca, A; Laurenti, L; Leone, G; Ortona, L; Piccirillo, N; Rutella, S; Sica, S; Sorà, F | 1 |
| Burra, P; Cavallari, A; Duvoux, C; Johnston, A; Lake, J; Levy, G; Mayer, AD; Mies, S; Pollard, SG; Varo, E; Villamil, F | 1 |
| Andres, A; Dominguez-Gil, B; Gonzalez, E; Herrero, JC; Latorre, A; Manzanares, C; Morales, E; Morales, JM; Munoz, MA; Ortiz, M; Sierra, P; Torres, A | 1 |
| Kanamori, H; Kodama, F; Okamoto, H; Sekiyama, K; Sugata, F; Yoshiba, M | 1 |
| Fukawa, H; Harano, H; Kanamori, H; Kodama, F; Maruta, A; Matsuzaki, M; Miyashita, H; Motomura, S; Okubo, T; Yoshiba, M | 1 |
| Chen, PM; Fan, FS; Hsiao, KI; Hu, ST; Liu, WT; Tzeng, CH | 1 |
| Azar, N; Cabrol, A; Cadranel, JF; Desruennes, M; Grippon, P; Leger, P; Lunel, F; Moussalli, J; Pauwels, A; Salmon, P | 1 |
29 review(s) available for cyclosporine and Hepatitis C
| Article | Year |
|---|---|
Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Insulin Resistance; Liver Transplantation; Recurrence; Virus Replication | 2013 |
Profile of alisporivir and its potential in the treatment of hepatitis C.
Topics: Antiviral Agents; Cyclosporine; Drug Resistance, Viral; Genotype; Hepacivirus; Hepatitis C; Humans; Virus Replication | 2013 |
Review article: HCV genotype 3 – the new treatment challenge.
Topics: Animals; Antiviral Agents; Cyclophilins; Cyclosporine; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Ribavirin; Viral Nonstructural Proteins | 2014 |
Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.
Topics: Cyclosporine; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Survival Rate; Tacrolimus | 2014 |
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.
Topics: Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Recurrence; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2014 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rheumatoid; Chronic Disease; Cryoglobulinemia; Cyclooxygenase 2 Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Hydroxychloroquine; Interferon-alpha; Methotrexate; Penicillamine; Purpura | 2008 |
Cyclophilin inhibitors.
Topics: Antiviral Agents; Cyclophilins; Cyclosporine; Cyclosporins; Drug Discovery; Hepacivirus; Hepatitis C; Humans; Virus Replication | 2009 |
Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Clinical Trials, Phase II as Topic; Cyclophilins; Cyclosporine; Disease Models, Animal; Hepacivirus; Hepatitis C; Humans; Virus Replication | 2010 |
Cyclophilin inhibitors for the treatment of HCV infection.
Topics: Cell Line; Clinical Trials as Topic; Cyclophilin A; Cyclophilins; Cyclosporine; Cyclosporins; Hepacivirus; Hepatitis C; Humans; Peptidylprolyl Isomerase; RNA, Viral; Viral Nonstructural Proteins; Viral Proteins; Virus Replication | 2010 |
Immunosuppression and HCV recurrence after liver transplantation.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Tacrolimus | 2012 |
Optimization of the use of Calcineurin inhibitors in liver transplantation.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Drug Administration Schedule; Drug Substitution; Graft Rejection; Hepatitis C; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis.
Topics: Antiviral Agents; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Tacrolimus | 2013 |
The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice.
Topics: Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Randomized Controlled Trials as Topic; Recurrence | 2012 |
Immunosuppression in HCV-positive liver-transplant recipients.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Cyclophilin inhibitors for hepatitis C therapy.
Topics: Antiviral Agents; Cyclophilins; Cyclosporine; Cyclosporins; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Nonstructural Proteins | 2013 |
[Treatment of fulminant hepatitis C or subacute hepatitis C].
Topics: Acute Disease; Antiviral Agents; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-beta; Liver Failure; Sorption Detoxification | 2004 |
Review article: hepatitis C virus and calcineurin inhibition after renal transplantation.
Topics: Calcineurin Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Virus Replication | 2005 |
[Current approaches for developing new anti-HCV agents and analyses of HCV replication using anti-HCV agents].
Topics: Antiviral Agents; Cyclosporine; Depression, Chemical; DNA Replication; DNA, Viral; Drug Design; Drug Evaluation, Preclinical; Genome, Viral; Hepacivirus; Hepatitis C; Immunosuppressive Agents; Replicon; Virus Replication | 2005 |
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients.
Topics: Autoimmune Diseases; Cyclosporine; Hepatitis C; Humans | 2006 |
Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.
Topics: Biopsy; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Recurrence; Research Design; Risk; Tacrolimus; Treatment Outcome | 2007 |
Recurrent viral liver disease (hepatitis B and C) after liver transplantation.
Topics: Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Immune Tolerance; Immunization, Passive; Immunoglobulins; Liver Transplantation; Nucleic Acid Synthesis Inhibitors; Recurrence; Risk Factors | 2007 |
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
Topics: Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Hepatitis C; Humans; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2007 |
Renal dysfunction associated with liver transplantation.
Topics: Chronic Disease; Cyclosporine; Hepatitis C; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Failure; Liver Transplantation; Prostaglandins; Renal Dialysis; Renal Insufficiency; Tacrolimus | 1995 |
[Interferon treatment of type C fulminant hepatitis].
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Hepatitis C; Humans; Interferons; Male; Methylprednisolone | 1994 |
[Treatment of type C fulminant and subfulminant hepatitis--featuring antiviral and immunosuppressive treatment].
Topics: Antiviral Agents; Cyclosporine; Hemofiltration; Hepatic Encephalopathy; Hepatitis C; Humans; Immunosuppressive Agents; Interferons | 1995 |
[Changes of serum GBV-C RNA levels under administration of interferon and cyclosporine for patients with GBV infected hepatitis].
Topics: Adult; Biomarkers; Chronic Disease; Cyclosporine; Flaviviridae; Hepatitis C; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Interferons; RNA, Viral | 1997 |
Liver transplantation: changing goals in immunosuppression.
Topics: Child; Cyclosporine; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Recurrence; Survival Rate; Tacrolimus | 1998 |
[Clinical studies in liver transplantation].
Topics: Carcinoma, Hepatocellular; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Multicenter Studies as Topic; Postoperative Complications; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Tacrolimus | 2000 |
Management of recurrent hepatitis C after liver transplantation.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis; Liver Transplantation; Ribavirin; Secondary Prevention; Tacrolimus | 2001 |
37 trial(s) available for cyclosporine and Hepatitis C
| Article | Year |
|---|---|
Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study.
Topics: Adolescent; Adult; Aminoisobutyric Acids; Antiviral Agents; Area Under Curve; Cross-Over Studies; Cyclosporine; Drug Interactions; Female; Graft Rejection; Healthy Volunteers; Hepatitis C; Humans; Immunosuppressive Agents; Leucine; Liver Transplantation; Male; Middle Aged; Oligopeptides; Proline; Prospective Studies; Quinolines; Secondary Prevention; Tacrolimus; Thiazoles; Young Adult | 2018 |
Sirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates.
Topics: Adult; Cyclosporine; Drug Substitution; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Sirolimus; Time Factors; Treatment Outcome; Viral Load; Virus Replication | 2013 |
Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients.
Topics: Antiviral Agents; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2014 |
REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.
Topics: Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Tacrolimus | 2014 |
A pharmacokinetic-viral kinetic model describes the effect of alisporivir as monotherapy or in combination with peg-IFN on hepatitis C virologic response.
Topics: Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Male; Models, Biological | 2014 |
Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir.
Topics: 2-Naphthylamine; Adolescent; Adult; Anilides; Antiviral Agents; Area Under Curve; Carbamates; Cyclopropanes; Cyclosporine; Drug Administration Schedule; Female; Healthy Volunteers; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Sulfonamides; Tacrolimus; Uracil; Valine; Young Adult | 2015 |
Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
Topics: Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Glucose Tolerance Test; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Insulin; Insulin Resistance; Kidney Transplantation; Liver; Middle Aged; Prospective Studies; Risk Factors; RNA, Viral; Tacrolimus; Transplant Recipients | 2016 |
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection.
Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cyclosporine; Drug Dosage Calculations; Drug Therapy, Combination; Female; Hepatitis C; Humans; Immunosuppressive Agents; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Models, Biological; Proline; Ritonavir; Sulfonamides; Tacrolimus; Uracil; Valine; Young Adult | 2016 |
Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection?
Topics: Aged; Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Male; Pilot Projects; Prednisone; RNA, Messenger; RNA, Viral; Viral Load | 2009 |
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
Topics: Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Tacrolimus | 2010 |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Calcineurin Inhibitors; Chi-Square Distribution; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Spain; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Placebos; Polyethylene Glycols; Recombinant Proteins; Transaminases; Treatment Outcome; Young Adult | 2011 |
Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
Topics: Adolescent; Adult; Antiviral Agents; Area Under Curve; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Oligopeptides; Tacrolimus; Young Adult | 2011 |
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.
Topics: Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Induction Chemotherapy; Interferon-alpha; Kidney; Liver Cirrhosis; Liver Transplantation; Logistic Models; Maintenance Chemotherapy; Male; Middle Aged; Placebos; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Treatment Outcome; Viral Load | 2012 |
Pharmacokinetics of cyclosporine pre- and post-liver transplantation.
Topics: Adult; Alcoholism; Cholangitis, Sclerosing; Cyclosporine; Female; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Period | 2003 |
Oral erosive/ulcerative lichen planus: preliminary findings in an open trial of sulodexide compared with cyclosporine (ciclosporin) therapy.
Topics: Adult; Anticoagulants; Cyclosporine; Female; Glycosaminoglycans; Hepatitis C; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Oral Ulcer; Treatment Outcome | 2003 |
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
Topics: Adult; Biopsy, Needle; Cyclosporine; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; RNA, Viral; Tacrolimus; Treatment Outcome | 2004 |
Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Severity of Illness Index | 2005 |
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Placebos; Recombinant Fusion Proteins; Recurrence; Time Factors; Virus Replication | 2004 |
Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-beta; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Safety; Viral Load | 2005 |
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
Topics: Aged; Cyclosporine; Disease Progression; Female; Hepacivirus; Hepatitis C; Humans; Immunocompetence; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Recurrence; Regression Analysis; RNA, Messenger; RNA, Viral | 2006 |
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Fusion Proteins; Recurrence; Steroids; Survival Rate; Treatment Outcome | 2006 |
Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tacrolimus | 2006 |
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Female; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Middle Aged; Mycophenolic Acid; Recurrence; Treatment Outcome | 2007 |
The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cyclophilin A; Cyclophilins; Cyclosporine; Double-Blind Method; Drug Resistance, Viral; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Male; Middle Aged; Peptidylprolyl Isomerase; Placebos; Virus Replication | 2008 |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease.
Topics: Brain; Cyclosporine; Drug Therapy, Combination; Electroencephalography; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Incidence; Liver Transplantation; Magnetic Resonance Imaging; Neurotoxins; Survival Rate; Tacrolimus; Tomography, X-Ray Computed | 1994 |
Alpha-interferon for acute hepatitis C in liver transplant patients.
Topics: Alanine Transaminase; Cyclosporine; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recombinant Proteins; RNA, Viral; Tacrolimus; Time Factors | 1995 |
Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Combined Modality Therapy; Cyclosporine; Female; Hepatic Encephalopathy; Hepatitis B; Hepatitis C; Hepatitis E; Hepatitis, Viral, Human; Humans; Infant; Interferon-beta; Liver; Male; Middle Aged; Necrosis | 1995 |
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Topics: Adult; Aged; Alanine Transaminase; Azathioprine; Base Sequence; Biopsy; Chronic Disease; Creatinine; Cyclosporine; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Histocompatibility Testing; Humans; Interferon Type I; Kidney; Kidney Transplantation; Liver; Male; Middle Aged; Molecular Sequence Data; Prospective Studies; Recombinant Proteins; RNA, Viral | 1995 |
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Emulsions; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reoperation; RNA, Viral; Survival Rate; Tacrolimus | 1998 |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients.
Topics: Adult; Aged; Cyclosporine; Female; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Neoplasms; Male; Methylprednisolone; Middle Aged; Recurrence; RNA, Viral; Tacrolimus | 1998 |
Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Retrospective Studies; Tacrolimus | 1998 |
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation.
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; RNA, Messenger; RNA, Viral; Time Factors | 1999 |
A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Patient Selection; Postoperative Complications; Prospective Studies; Reoperation; Safety; Survival Rate; Time Factors | 2000 |
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).
Topics: Administration, Oral; Alkaline Phosphatase; Bilirubin; Cyclosporine; Drug Monitoring; Female; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Racial Groups; Regression Analysis; Safety; Time Factors | 2002 |
141 other study(ies) available for cyclosporine and Hepatitis C
| Article | Year |
|---|---|
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors.
Topics: Antiviral Agents; Clinical Trials as Topic; Cyclophilins; Cyclosporine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Hepacivirus; Hepatitis C; Humans; Replicon; Ribavirin; Viral Nonstructural Proteins | 2009 |
SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.
Topics: Animals; Antiviral Agents; Cell Line; Cells, Cultured; Cyclophilin A; Cyclosporins; Dogs; Dose-Response Relationship, Drug; Enzyme Activation; Haplorhini; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Immunosuppressive Agents; Interleukin-2; Jurkat Cells; Leukocytes, Mononuclear; Mice; Molecular Structure; Rats; RNA, Viral; Virus Replication | 2010 |
From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cyclophilins; Cyclosporine; Cyclosporins; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Host-Pathogen Interactions; Humans; Lactones; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Spiro Compounds; Structure-Activity Relationship | 2014 |
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cyclophilin A; Drug Synergism; Glycine; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Indoleacetic Acids; Mice, Inbred NOD; Mice, SCID; Models, Molecular; Protein Binding; Replicon; Structure-Activity Relationship; Virus Replication | 2015 |
Drug-Drug Interactions With Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir-Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or Cirrhosis.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Organ Transplantation; Proline; Retrospective Studies; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine | 2022 |
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus.
Topics: Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Viral Nonstructural Proteins | 2023 |
The hepatitis E virus ORF1 hypervariable region confers partial cyclophilin dependency.
Topics: Cyclophilins; Cyclosporine; Female; Hepacivirus; Hepatitis C; Hepatitis E virus; Humans; Pregnancy; Virus Replication | 2023 |
Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cyclosporine; Female; Hepacivirus; Hepatitis C; Humans; Kidney Transplantation; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Postoperative Complications; Proline; Ritonavir; Sulfonamides; Sustained Virologic Response; Tacrolimus; Uracil; Valine | 2019 |
Discovery of a novel 9-position modified second-generation anti-HCV candidate via bioconversion and semi-synthesis of FR901459.
Topics: Alkylation; Amino Acid Sequence; Antiviral Agents; Cyclophilins; Cyclosporine; Drug Design; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Solubility; Structure-Activity Relationship | 2020 |
The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype.
Topics: Antiviral Agents; Benzimidazoles; Calcineurin Inhibitors; Carbamates; Cell Line; Cyclosporine; Everolimus; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Liver Transplantation; Pyrrolidines; Sirolimus; Sofosbuvir; Valine; Virus Replication | 2018 |
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
Topics: Amino Acid Substitution; Antiviral Agents; Cyclophilin A; Cyclosporine; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Humans; Viral Nonstructural Proteins; Virus Replication | 2018 |
Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Therapy; Comorbidity; Cyclosporine; Etanercept; Female; Hepatitis B; Hepatitis C; Humans; Infliximab; Interleukin-17; Latent Tuberculosis; Male; Methotrexate; Middle Aged; Non-alcoholic Fatty Liver Disease; Psoriasis; Ustekinumab | 2018 |
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.
Topics: Aged; Anemia; Antiviral Agents; Carbamates; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Tacrolimus; Valine | 2019 |
Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients.
Topics: Aged; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Oligopeptides; Protease Inhibitors; Recurrence; RNA; Treatment Outcome | 2014 |
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance.
Topics: Antiviral Agents; Cyclophilin A; Cyclophilins; Cyclosporine; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Replicon; Viral Nonstructural Proteins; Virus Replication | 2014 |
Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.
Topics: Adenosine; Antiviral Agents; Biological Assay; Cell Culture Techniques; Cell Line; Cell Survival; Cyclosporine; Furans; Genotype; Hepacivirus; Hepatitis C; High-Throughput Screening Assays; Humans; Luciferases, Renilla; Mutagenesis, Site-Directed; Oligopeptides; Pyridines; Replicon; Thiophenes; Viral Nonstructural Proteins; Virus Replication | 2014 |
Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
Topics: Antiviral Agents; Biomarkers; Cyclosporine; Dose-Response Relationship, Immunologic; Drug Interactions; Drug Monitoring; End Stage Liver Disease; Female; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Liver Transplantation; Male; Middle Aged; Oligopeptides; Predictive Value of Tests; Recurrence; Retrospective Studies; RNA, Messenger; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2014 |
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition.
Topics: Animals; Antiviral Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Cyclophilins; Cyclosporine; Cyclosporins; Dogs; Hepacivirus; Hepatitis C; Humans; Hydrophobic and Hydrophilic Interactions; Immunosuppressive Agents; Liver-Specific Organic Anion Transporter 1; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Peptidyl-Prolyl Isomerase F; Rats; Structure-Activity Relationship; Virus Replication | 2014 |
Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.
Topics: Animals; Antiviral Agents; Cyclosporine; Disease Models, Animal; Hepacivirus; Hepatitis C; Lactic Acid; Liver; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Virus Replication | 2015 |
Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report.
Topics: Aged; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Living Donors; Male; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Simeprevir; Tacrolimus; Treatment Outcome | 2015 |
Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach.
Topics: Alkynes; Antiviral Agents; Benzoxazines; Cyclopropanes; Cyclosporine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Erythromycin; Hepatitis C; Humans; Liver; Liver-Specific Organic Anion Transporter 1; Nonlinear Dynamics; Organic Anion Transporters; Rifampin; Ritonavir; Simeprevir; Viral Nonstructural Proteins | 2016 |
Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection.
Topics: Antiviral Agents; Cell Line, Tumor; Cyclophilins; Cyclosporine; Endoplasmic Reticulum; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Kinetics; Sofosbuvir; Viral Nonstructural Proteins | 2016 |
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.
Topics: Antibodies, Monoclonal; Basiliximab; Biopsy; Cyclosporine; Drug Therapy, Combination; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Polymerase Chain Reaction; Recombinant Fusion Proteins; Recurrence; Retrospective Studies; RNA, Viral; Survival Rate; Tacrolimus | 2016 |
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Databases as Topic; Female; Follow-Up Studies; Graft Survival; Hepatitis C; Hepatitis, Autoimmune; HLA Antigens; HLA-A Antigens; HLA-DR Antigens; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; National Institute of Diabetes and Digestive and Kidney Diseases (U.S.); Tacrolimus; Treatment Outcome; United States | 2008 |
Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin?
Topics: Antiviral Agents; Cohort Studies; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kinetics; Liver; Liver Transplantation; Odds Ratio; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2008 |
Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
Topics: Alanine Transaminase; Cyclosporine; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Immunosuppressive Agents; Japan; Kidney Transplantation; Postoperative Complications; Retrospective Studies; RNA, Viral; Tacrolimus; Virus Replication | 2008 |
Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report.
Topics: Adult; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Treatment Outcome | 2008 |
Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection.
Topics: Aged; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Etanercept; Follow-Up Studies; Hepatitis C; Humans; Immunoglobulin G; Injections, Subcutaneous; Kidney Failure, Chronic; Liver Function Tests; Male; Polycystic Kidney Diseases; Psoriasis; Receptors, Tumor Necrosis Factor; Renal Dialysis; Severity of Illness Index; Treatment Outcome | 2008 |
Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Topics: Analysis of Variance; Blotting, Western; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Cyclosporine; DNA Primers; Hepacivirus; Hepatitis C; Hepatocytes; Host-Pathogen Interactions; Humans; Interferon-alpha; Liver; Reverse Transcriptase Polymerase Chain Reaction; Virus Replication | 2009 |
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Male; Middle Aged; Odds Ratio; Recurrence; Regression Analysis; Tacrolimus; Treatment Outcome | 2009 |
Application of rituximab to hepatitis C-positive, ABO-incompatible renal transplantation.
Topics: ABO Blood-Group System; Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Combined Modality Therapy; Creatinine; Cyclosporine; Hepacivirus; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Plasmapheresis; Rituximab; RNA, Viral | 2009 |
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Interferons; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome | 2009 |
Neurologic complications in adult living donor liver transplant patients: an underestimated factor?
Topics: Brain Diseases; Cohort Studies; Cyclosporine; Female; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Seizures; Tacrolimus; Treatment Outcome | 2010 |
Inhibitory effects of cyclosporine on human regulatory T cells in vitro.
Topics: CD4-Positive T-Lymphocytes; Cell Culture Techniques; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Hepatitis C; Humans; Immunophenotyping; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Liver Transplantation; Recurrence; T-Lymphocytes, Regulatory | 2009 |
Preemptive therapy in adult liver transplant recipients in CMV-endemic area.
Topics: Adult; Cadaver; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Endemic Diseases; Female; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Korea; Liver Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Tissue Donors | 2010 |
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Transplantation; Prednisone; Retrospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 2010 |
Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
Topics: Acyclovir; Antiviral Agents; Corticosterone; Cyclosporine; Cytomegalovirus Infections; Female; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Tacrolimus | 2010 |
A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.
Topics: Amino Acid Sequence; Blotting, Western; Cell Line; Circular Dichroism; Cyclophilin A; Cyclosporine; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Viral; Hepacivirus; Hepatitis C; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Protein Conformation; Replicon; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; RNA, Viral; Sequence Homology, Amino Acid; Viral Nonstructural Proteins; Virus Replication | 2010 |
Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.
Topics: Adult; Antiviral Agents; Cyclosporine; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Virus Replication | 2011 |
Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
Topics: Cell Line; Cyclosporine; Gene Expression Regulation; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Immunity, Innate; Immunosuppressive Agents; Interferon Regulatory Factor-1; Interferon-alpha; Liver Transplantation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Up-Regulation; Viral Proteins; Virus Replication | 2011 |
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus.
Topics: Cyclosporine; Disease Progression; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus | 2010 |
Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
Topics: Antiviral Agents; Cholestasis, Intrahepatic; Cohort Studies; Cyclosporine; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Tacrolimus; Treatment Outcome | 2011 |
Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Topics: Adolescent; Aged; Antibodies, Viral; Azathioprine; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis C; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Steroids; Tacrolimus | 2011 |
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
Topics: Antiviral Agents; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Oligopeptides; Proline; Tacrolimus | 2011 |
Viral hepatitis: Ciclosporin versus tacrolimus for HCV transplant recipients.
Topics: Antiviral Agents; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Retrospective Studies; Secondary Prevention; Tacrolimus | 2011 |
Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection.
Topics: Animals; Antiviral Agents; Calcineurin Inhibitors; Chimera; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Interferon alpha-2; Interferon-alpha; Mice; Mice, SCID; Recombinant Proteins; Tacrolimus; Treatment Outcome; Viral Load; Virus Replication | 2012 |
Impact of calcineurin inhibitors on hepatitis C recurrence after liver transplantation.
Topics: Calcineurin Inhibitors; Cyclosporine; Female; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Secondary Prevention; Tacrolimus; Transplantation, Homologous | 2012 |
Of mice and men, calcineurin inhibitors and hepatitis C.
Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Tacrolimus; Virus Replication | 2012 |
Update on alisporivir in treatment of viral hepatitis C.
Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Cyclophilins; Cyclosporine; Drug Administration Schedule; Drug Design; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Humans | 2012 |
Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
Topics: Adult; Antiviral Agents; Area Under Curve; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Female; Hepatitis C; Humans; Immunosuppressive Agents; Male; Proline; Protease Inhibitors; Tacrolimus; Young Adult | 2012 |
A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus.
Topics: Antiviral Agents; Benzoflavones; Camellia sinensis; Catechin; Cell Line, Tumor; Cyclosporine; Drug Evaluation, Preclinical; Flavones; Hepacivirus; Hepatitis C; Humans; Phytotherapy; Reproducibility of Results; Tamoxifen | 2012 |
Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
Topics: Cyclophilin A; Cyclophilins; Cyclosporine; Gene Expression Regulation, Enzymologic; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; In Vitro Techniques; Mutant Proteins; Plasmids; RNA-Dependent RNA Polymerase; RNA, Viral; Transcription, Genetic; Virus Replication | 2012 |
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Topics: Adipokines; Adult; Antiviral Agents; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lectins; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Sex Factors; Statistics, Nonparametric; Tacrolimus; Time Factors; Young Adult | 2013 |
Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility.
Topics: Amino Acid Sequence; Antiviral Agents; Cyclosporine; DNA Mutational Analysis; Hepacivirus; Hepatitis C; Humans; Liver Transplantation; Molecular Sequence Data; Mutation, Missense; Point Mutation; Proline; Transplantation; Viral Nonstructural Proteins; Virus Replication | 2013 |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.
Topics: Alanine Transaminase; Antidepressive Agents, Second-Generation; Aspartate Aminotransferases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Hepatitis C; Humans; Liver Transplantation; Male; Mixed Function Oxygenases; Piperazines; Substance-Related Disorders; Tacrolimus; Triazoles | 2002 |
Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Recurrence; Retrospective Studies; Tacrolimus; Viral Load | 2002 |
A pilot study of the combination of cyclosporin A and interferon alfacon-1 for the treatment of hepatitis C in previous nonresponder patients.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Injections, Subcutaneous; Interferon Type I; Interferon-alpha; Male; Middle Aged; Pilot Projects; Probability; Recombinant Proteins; Remission Induction; Sampling Studies; Statistics, Nonparametric; Treatment Failure; Treatment Outcome | 2003 |
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation.
Topics: Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Tacrolimus | 2003 |
Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Leukocytes, Mononuclear; Liver; Male; Middle Aged; Recurrence; Renal Dialysis; RNA; RNA, Viral | 2003 |
A longitudinal study of children who received renal transplants 10-20 years ago.
Topics: Adult; Carcinoma, Renal Cell; Child; Child Development; Cyclosporine; Educational Status; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Kidney; Kidney Neoplasms; Kidney Transplantation; Longitudinal Studies; Male; Postoperative Complications; Pregnancy; Pregnancy Outcome; Reoperation; Survival Analysis | 2003 |
Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
Topics: Alkaline Phosphatase; Cyclosporine; Graft Rejection; Hepatitis C; Hepatocytes; Humans; Immunosuppressive Agents; Liver Transplantation; Microsomes, Liver; Retrospective Studies; Tacrolimus | 2003 |
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection.
Topics: Azathioprine; Creatinine; Cross-Over Studies; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Viral Load | 2004 |
[Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Topics: Acute Disease; Antineoplastic Agents; Blood Transfusion; Cyclosporine; Hepatitis C; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Red-Cell Aplasia, Pure | 2004 |
Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus.
Topics: Adult; Brazil; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisone; Racial Groups; Retrospective Studies; Tacrolimus | 2004 |
Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Disease Progression; Drug Therapy, Combination; Emulsions; Female; Glucocorticoids; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Recombinant Fusion Proteins; Tacrolimus; Treatment Outcome | 2004 |
[Association between diabetes mellitus and hepatitis C in kidney transplant patients].
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Graft Survival; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Multivariate Analysis; Odds Ratio; Postoperative Complications; Prevalence; Retrospective Studies | 2004 |
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
Topics: Adult; Age Factors; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Tacrolimus | 2005 |
Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Administration Schedule; Follow-Up Studies; Glucocorticoids; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Methylprednisolone; Middle Aged; Muromonab-CD3; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome | 2005 |
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
Topics: Amantadine; Antiviral Agents; Azathioprine; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Recurrence; Reproducibility of Results; RNA, Viral; Treatment Failure; Viral Load | 2005 |
The first one thousand liver transplants in Turin: a single-center experience in Italy.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Child; Child, Preschool; Cyclosporine; Fibrosis; Graft Survival; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Italy; Liver Neoplasms; Liver Transplantation; Middle Aged; Models, Statistical; Time Factors; Treatment Outcome | 2005 |
Treating hepatitis C: can you teach old dogs new tricks?
Topics: Antiviral Agents; Cyclophilins; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Peptidylprolyl Isomerase; RNA, Viral; Viral Nonstructural Proteins; Virus Replication | 2005 |
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
Topics: Adult; Aged; Biopsy; Cohort Studies; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prednisone; Recurrence; Severity of Illness Index; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Immunosuppression and outcomes of patients transplanted for hepatitis C.
Topics: Adrenal Cortex Hormones; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Recurrence; RNA, Messenger; RNA, Viral; Tacrolimus; Treatment Outcome | 2006 |
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Topics: Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Hepacivirus; Hepatitis C; Humans; Osmolar Concentration; RNA, Viral; Virus Replication | 2006 |
Cyclosporin a for treatment of hepatitis C virus after liver transplantation.
Topics: Cyclosporine; Hepatitis C; Humans; Liver Transplantation; Living Donors | 2006 |
Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Retrospective Studies; Survival Rate; Tissue Donors | 2006 |
A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.
Topics: Biopsy; Cyclosporine; Databases, Factual; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.
Topics: Animals; Antiviral Agents; Cyclophilins; Cyclosporine; Genotype; Hepacivirus; Hepatitis C; Humans; Immunohistochemistry; Immunosuppression Therapy; Interferon alpha-2; Interferon-alpha; Mice; Mice, SCID; Polyethylene Glycols; Recombinant Proteins; Replicon; RNA, Viral; Serum Albumin; Transplantation Chimera; Viral Core Proteins | 2007 |
Diabetes mellitus after kidney transplantation: a French multicentre observational study.
Topics: Adult; Blood Glucose; Body Mass Index; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Emulsions; Fasting; Female; France; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors | 2007 |
Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Hepatitis C; HIV Infections; Humans; Immunoglobulin G; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2007 |
Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.
Topics: Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Pilot Projects; Virus Replication | 2007 |
Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.
Topics: Amino Acid Sequence; Antiviral Agents; Cell Line, Tumor; Cyclosporine; Drug Resistance, Viral; Genotype; Hepacivirus; Hepatitis C; Humans; Molecular Sequence Data; Mutation; Polymorphism, Genetic; Replicon; Viral Nonstructural Proteins | 2007 |
Hepatitis C virus kinetics in chimeric mice during antiviral therapy.
Topics: Animals; Antiviral Agents; Chimera; Cyclosporine; Hepacivirus; Hepatitis C; Interferon alpha-2; Interferon-alpha; Mice; Polyethylene Glycols; Recombinant Proteins | 2007 |
Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
Topics: Aged; Alkaline Phosphatase; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Middle Aged; Pilot Projects; Prednisone; RNA, Viral; Tacrolimus; Viral Load | 2007 |
Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
Topics: Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interferons; Recurrence; Signal Transduction; Tacrolimus; Virus Replication | 2008 |
Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation.
Topics: Antiviral Agents; Cohort Studies; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Living Donors; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Tacrolimus | 2007 |
Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antigens, CD; Antiviral Agents; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cyclosporine; Dioxygenases; Disease Models, Animal; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver; Mice; Mice, Nude; Phosphoproteins; Tetraspanin 28; Virus Replication | 2008 |
Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
Topics: Adult; Chronic Disease; Cyclosporine; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prevalence; Retrospective Studies; Survival Rate; Transplantation, Homologous | 1995 |
Rejection and hepatitis in liver transplants.
Topics: Adult; Cyclosporine; Diagnostic Errors; Follow-Up Studies; Graft Rejection; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Retrospective Studies; Tacrolimus; Time Factors | 1994 |
Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
Topics: Adult; Bilirubin; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Follow-Up Studies; Graft Rejection; Hepatitis C; Humans; Liver Transplantation; Middle Aged; Recurrence; Reoperation; Tacrolimus; Treatment Failure; Treatment Outcome | 1994 |
Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
Topics: Cyclosporine; Drug Monitoring; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Incidence; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Transplantation; Muromonab-CD3; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1994 |
Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Survival; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Kidney Transplantation; Pilot Projects; Retrospective Studies; Tacrolimus; Time Factors | 1995 |
Hepatitis C virus infection in renal transplant recipients: prognostic significance of chronic transaminase elevation.
Topics: Actuarial Analysis; Adolescent; Adult; Analysis of Variance; Azathioprine; Biomarkers; Chi-Square Distribution; Cyclosporine; Female; Follow-Up Studies; Hepatitis C; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Regression Analysis; Retrospective Studies; Survival Rate; Time Factors; Transaminases | 1995 |
Conversion from cyclosporine Sandimmun to cyclosporine neoral in liver transplant patients with cholestasis or external biliary drainage.
Topics: Administration, Oral; Adult; Autoimmune Diseases; Bile; Cholestasis; Cyclosporine; Drainage; Female; Hepatitis C; Humans; Injections, Intravenous; Intestinal Absorption; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged | 1995 |
Reversal of chronic rejection after treatment failure with FK506 and RS61443.
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Tacrolimus | 1993 |
Hepatitis C virus infection in renal transplantation.
Topics: Azathioprine; Cyclosporine; Hepatitis C; Humans; Kidney Transplantation; Liver; Pancreas Transplantation; Polymerase Chain Reaction; Postoperative Complications; Ribavirin | 1995 |
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Middle Aged; Prednisone | 1995 |
Sandimmun-Neoral in liver transplantation: a remarkable improvement in long-term immunosuppression.
Topics: Administration, Oral; Adult; Cyclosporine; Female; Hepatitis C; Humans; Intestinal Absorption; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged | 1994 |
Fulminant hepatitis following bone marrow transplantation in hepatitis B virus carrier siblings.
Topics: Adult; Bone Marrow Transplantation; Carrier State; Cyclosporine; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Male | 1994 |
Increased susceptibility for CsA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C.
Topics: Chemical and Drug Induced Liver Injury; Chronic Disease; Cyclosporine; Disease Susceptibility; Hepatitis C; Humans; Kidney Transplantation; Liver Function Tests; Retrospective Studies | 1993 |
Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant recipient.
Topics: Cerebellar Ataxia; Cyclosporine; Dysarthria; Hepatitis C; Humans; Leukoencephalopathy, Progressive Multifocal; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged | 1993 |
[Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C].
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Cyclosporine; Female; Hepatitis C; Humans; Interferon-alpha; Kidney Transplantation; Male; Middle Aged | 1996 |
Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis.
Topics: Anti-Inflammatory Agents; Autopsy; Cyclosporine; Fatal Outcome; Female; Glucocorticoids; Hepatic Encephalopathy; Hepatitis C; Humans; Immunosuppressive Agents; Liver; Liver Failure, Acute; Middle Aged; Multiple Sclerosis; Necrosis; Steroids | 1996 |
The long-term course of hepatitis C after kidney transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Child; Cyclosporine; Female; Graft Rejection; Hemosiderosis; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisolone; Prevalence; Retrospective Studies; Treatment Outcome | 1996 |
Long-term follow-up in hepatitis C patients with respect to immunosuppression.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Graft Rejection; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Neoplasms; Liver Transplantation; Postoperative Complications; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus | 1996 |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Follow-Up Studies; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoma; Neoplasms; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1996 |
[Autoimmune enteropathy--difficulties in diagnosis and treatment].
Topics: Autoimmune Diseases; Child, Preschool; Cyclosporine; Diarrhea; Hepatitis C; Humans; Intestinal Diseases; Male; Prednisone; Recurrence | 1996 |
[Therapeutic principles after liver transplantation].
Topics: Azathioprine; Cyclosporine; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Postoperative Complications; Prednisolone | 1996 |
Cyclosporine therapy affects aminotransferase activity but not hepatitis C virus RNA levels in chronic hepatitis C.
Topics: Administration, Oral; Alanine Transaminase; Clinical Enzyme Tests; Cyclosporine; Female; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Male; Middle Aged; RNA, Viral; Time Factors | 1997 |
Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parameters.
Topics: Actuarial Analysis; Cyclosporine; Cytokines; Drug Therapy, Combination; Extracellular Matrix Proteins; Fibronectins; Gene Expression Regulation; Glutathione Transferase; Graft Rejection; Hepatitis C; Humans; Hyaluronic Acid; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Interleukin-8; Laminin; Liver Transplantation; Prednisolone; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1997 |
Persistent cortical blindness after cyclosporine leukoencephalopathy.
Topics: Blindness, Cortical; Brain Diseases; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Time Factors | 1997 |
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.
Topics: Alanine Transaminase; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Genome, Viral; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Time Factors | 1998 |
Is long-term chronic immunosuppression therapy detrimental in hepatitis C virus-positive renal transplant patients?
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Cyclosporine; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver; Male; Middle Aged; RNA, Viral | 1998 |
Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
Topics: Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Muromonab-CD3; Neoplasms; Postoperative Complications; Prednisone; Retrospective Studies; Time Factors; Transplantation, Homologous | 1998 |
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Monitoring, Immunologic; Neoplasms, Second Primary; Opportunistic Infections; Postoperative Complications; Retrospective Studies | 1998 |
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
Topics: Antibodies, Monoclonal; Cyclosporine; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1998 |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Prednisone; Recurrence; Reoperation; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Risk factors for recurrence of hepatitis C after liver transplantation.
Topics: Adult; Biopsy; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Predictive Value of Tests; Recurrence; Retrospective Studies; Risk Factors; RNA, Viral; Transaminases | 1998 |
High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Middle Aged; Morbidity; Recurrence; Risk Factors; Survival Rate; Time Factors | 1998 |
Long-term evolution of anti-HCV-positive renal transplant recipients.
Topics: Adult; Azathioprine; Blood Transfusion; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Survival Rate; Time Factors | 1998 |
Hepatitis C virus infection after renal transplantation: prevalence and course of morphologic lesions.
Topics: Biopsy; Cyclosporine; Follow-Up Studies; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Liver; Methylprednisolone; Postoperative Complications; Prevalence; Time Factors; Viremia | 1998 |
Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Mycophenolic Acid; Recurrence; Retrospective Studies; RNA, Viral; Time Factors; Virus Replication | 1998 |
Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Muromonab-CD3; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases.
Topics: Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Female; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; RNA, Viral; Skin Diseases; Time Factors | 1999 |
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Topics: Adult; Cyclosporine; Follow-Up Studies; Graft Survival; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Reoperation; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 1999 |
Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Topics: Adult; Alanine Transaminase; Azathioprine; Biopsy; Cholestasis, Intrahepatic; Cyclosporine; Fatal Outcome; Female; Follow-Up Studies; gamma-Glutamyltransferase; Genotype; Glucocorticoids; Hepacivirus; Hepatitis C; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Liver Cirrhosis; Male; Methylprednisolone; Middle Aged; RNA, Viral; Survival Rate; Viremia | 1999 |
[Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Female; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Male; Splenectomy; Time Factors | 1999 |
Diabetes mellitus and liver transplantation in adults.
Topics: Adult; Aged; Azathioprine; Blood Glucose; Brazil; Cyclosporine; Diabetes Mellitus; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies | 1999 |
Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Prednisone; Recurrence; Retrospective Studies; RNA, Viral; Time Factors | 1999 |
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation.
Topics: Adult; Aged; Cyclosporine; Dimerization; Female; Hepatitis C; Humans; Immunohistochemistry; Liver Transplantation; Male; Middle Aged; NF-kappa B; Recurrence; RNA, Viral; Tacrolimus | 2000 |
Effects of hepatitis C virus infection on cyclosporine trough levels in renal transplant patients.
Topics: Adult; Cyclosporine; Female; Hepacivirus; Hepatitis Antibodies; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Period | 2000 |
Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
Topics: Algorithms; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Lymphoma, B-Cell; Lymphoproliferative Disorders; Middle Aged; Prednisone; Tomography, X-Ray Computed | 2000 |
Hepatitis C after liver transplantation.
Topics: Cyclosporine; Disease Progression; Drug Therapy, Combination; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Prognosis; Recurrence; Renal Insufficiency; Risk Factors; Sepsis; Tacrolimus; Treatment Outcome | 2000 |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Topics: Administration, Oral; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2001 |
Transplanted livers and kidneys for HIV+ people.
Topics: Antiretroviral Therapy, Highly Active; Cyclosporine; Hepatitis B; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Kidney Transplantation; Liver Failure; Liver Transplantation; Lovastatin; Pravastatin; Renal Insufficiency; San Francisco | 2001 |
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatitis C; HIV; HIV Infections; Humans; Leukemia, Myeloid, Acute; Remission Induction; RNA, Viral; Transplantation, Homologous; Viremia | 2002 |
Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Tacrolimus | 2002 |
Activation of hepatitis C virus following immunosuppressive treatment.
Topics: Cyclosporine; Hepacivirus; Hepatitis C; Humans; RNA, Viral; Virus Activation | 1992 |
Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Hepatitis C; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male | 1992 |
Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C.
Topics: Adult; Base Sequence; Bone Marrow Transplantation; Cyclosporine; DNA, Viral; Female; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Leukemia, Myeloid, Acute; Molecular Sequence Data | 1991 |
Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months.
Topics: Adolescent; Adult; Cholangitis; Chronic Disease; Cyclosporine; Female; Heart Transplantation; Hepatitis B; Hepatitis C; Hepatitis E; Humans; Liver; Liver Diseases; Male; Middle Aged; Retrospective Studies | 1991 |